These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27330162)

  • 21. Juvenile-onset systemic sclerosis: children are not small adults.
    Denton CP; Derrett-Smith EC
    Rheumatology (Oxford); 2009 Feb; 48(2):96-7. PubMed ID: 19028745
    [No Abstract]   [Full Text] [Related]  

  • 22. Autologous HSCT in systemic sclerosis: a step forward.
    Farge D; Gluckman E
    Lancet; 2011 Aug; 378(9790):460-2. PubMed ID: 21777973
    [No Abstract]   [Full Text] [Related]  

  • 23. [Do specific antifibrotic properties of immunosuppressive drugs used in the treatment of systemic sclerosis exist?].
    Verrecchia F; Michel L; Keshtmand H; Wang Y; Launay D; Farge D
    Rev Med Interne; 2009 Nov; 30(11):955-62. PubMed ID: 19349102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic sclerosis: from pathogenesis to targeted therapy.
    Denton CP
    Clin Exp Rheumatol; 2015; 33(4 Suppl 92):S3-7. PubMed ID: 26457375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunosuppression.
    Geissler EK
    Cancer Treat Res; 2009; 146():23-43. PubMed ID: 19415191
    [No Abstract]   [Full Text] [Related]  

  • 26. [Systemic sclerosis : What is currently available for treatment?].
    Becker MO
    Internist (Berl); 2016 Dec; 57(12):1155-1163. PubMed ID: 27796473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current status of immunosuppressive minimization and tolerance strategies.
    Brouard S; Budde K
    Transpl Int; 2015 Aug; 28(8):889-90. PubMed ID: 26178312
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of scleroderma].
    Guillevin L; Ortonne JP
    Ann Med Interne (Paris); 1983; 134(8):754-65. PubMed ID: 6364917
    [No Abstract]   [Full Text] [Related]  

  • 29. Oral tacrolimus for the treatment of generalized morphea.
    Hirohata A; Hanafusa T; Igawa K; Inoue-Nishimoto T; Mabuchi-Kiyohara E; Nishide M; Yokozeki H; Ikegami R
    Eur J Dermatol; 2016; 26(1):112-3. PubMed ID: 26679400
    [No Abstract]   [Full Text] [Related]  

  • 30. Disappearance of circulating autoantibodies to RNA polymerase III in a patient with systemic sclerosis successfully treated with corticosteroid and methotrexate.
    Tanahashi K; Sugiura K; Muro Y; Akiyama M
    J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1453-4. PubMed ID: 24916000
    [No Abstract]   [Full Text] [Related]  

  • 31. Systemic sclerosis - a systematic overview: part 2 - immunosuppression, treatment of SSc-associated vasculopathy, and treatment of pulmonary arterial hypertension.
    Opitz C; Klein-Weigel PF; Riemekasten G
    Vasa; 2011 Jan; 40(1):20-30. PubMed ID: 21283970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristics of scleroderma overlap syndromes: comparisons with pure scleroderma.
    Foocharoen C; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R
    Int J Rheum Dis; 2016 Sep; 19(9):913-23. PubMed ID: 27126733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclophosphamide for scleroderma lung disease.
    Martinez FJ; McCune WJ
    N Engl J Med; 2006 Jun; 354(25):2707-9. PubMed ID: 16790705
    [No Abstract]   [Full Text] [Related]  

  • 34. Systemic sclerosis sine scleroderma: a case report of anterior uveitis.
    Borges T; Vilaça J; Ferreira S; Chora I; Silva S; Dias C
    Reumatismo; 2015 Jun; 67(1):21-5. PubMed ID: 26150271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Systemic sclerosis].
    Kleinert S; Tony HP; Kneitz C
    Internist (Berl); 2006 Oct; 47(10):1051-61; quiz 1062. PubMed ID: 16972070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclophosphamide in systemic sclerosis: light and shadows.
    Vlachoyiannopoulos PG; Ioannidis JP
    Clin Exp Rheumatol; 2004; 22(5):551-2. PubMed ID: 15485005
    [No Abstract]   [Full Text] [Related]  

  • 37. Fibrosing alveolitis in systemic sclerosis: the need for early screening and treatment.
    Sahhar J; Littlejohn G; Conron M
    Intern Med J; 2004 Nov; 34(11):626-38. PubMed ID: 15546457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indirect evidence for the efficacy of methotrexate in diffuse systemic sclerosis.
    Low AH; Lee P
    J Rheumatol; 2008 Nov; 35(11):2286. PubMed ID: 19004063
    [No Abstract]   [Full Text] [Related]  

  • 39. Is there a customised immunosuppressive regimen for patients transplanted with hepatocellular carcinoma?
    Majno P; Giostra E; Mentha G;
    J Hepatol; 2005 Oct; 43(4):577-84. PubMed ID: 16118027
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunosuppressive drugs in dermatology--benefits and threats.
    Kowal A; Warmińska J; Krasowska D
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):14-21. PubMed ID: 15323159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.